Columbia Trust’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$2.81M Buy
17,954
+1,666
+10% +$255K 1.27% 16
2023
Q3
$2.54M Buy
16,288
+370
+2% +$61.1K 1.47% 16
2023
Q2
$2.63M Buy
15,918
+279
+2% +$45K 1.48% 15
2023
Q1
$2.42M Sell
15,639
-1,006
-6% -$162K 1.4% 14
2022
Q4
$2.94M Sell
16,645
-425
-2% -$73.4K 1.64% 13
2022
Q3
$2.79M Buy
17,070
+1,149
+7% +$194K 1.57% 10
2022
Q2
$2.83M Sell
15,921
-8
-0.1% -$1.43K 1.52% 11
2022
Q1
$2.87M Buy
15,929
+4,738
+42% +$806K 1.34% 15
2021
Q4
$1.81M Hold
11,191
0.96% 24
2021
Q3
$1.81M Buy
11,191
+311
+3% +$53.1K 0.95% 24
2021
Q2
$1.79M Sell
10,880
-1,047
-9% -$173K 1.02% 25
2021
Q1
$1.96M Sell
11,927
-91
-0.8% -$14.7K 1.21% 24
2020
Q4
$1.89M Buy
+12,018
New +$1.77M 1.31% 19
2020
Q2
$1.76M Sell
12,539
-1,739
-12% -$253K 1.57% 12
2020
Q1
$1.87M Buy
14,278
+1,470
+11% +$209K 2.05% 7
2019
Q4
$1.87M Buy
+12,808
New +$1.74M 1.66% 9

Other funds holding JNJ

Columbia Trust's JNJ Position: Q4 2023 in Review

Columbia Trust increased its Johnson & Johnson (JNJ) stake by 10% in Q4 2023, buying an estimated $255K and bringing the position to 17,954 shares worth $2.81M. The position accounts for 1.27% of the portfolio, ranked #16.

Columbia Trust first reported a position in JNJ in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.94M in Q4 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Columbia Trust held 17,954 shares of Johnson & Johnson worth $2.81M as of Q4 2023.
  • Columbia Trust bought 1,666 Johnson & Johnson shares in Q4 2023, an estimated $255K.
  • Johnson & Johnson made up 1.27% of Columbia Trust's portfolio in Q4 2023, its #16 holding.
  • Columbia Trust first reported a position in Johnson & Johnson in Q4 2019 and has held it in 16 quarters since.
  • Columbia Trust's Johnson & Johnson position peaked at $2.94M in Q4 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.